Log In
Print
BCIQ
Print
Print this Print this
 

CERE-110

  Manage Alerts
Collapse Summary General Information
Company Sangamo BioSciences Inc.
DescriptionAdeno-associated viral (AAV) vector encoding nerve growth factor (NGF)
Molecular Target Nerve growth factor (NGF)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat mild to moderate Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today